After 10 tough years of rehabilitation, Shane Hopkins considers himself lucky. 9News
"Our drug can target a number of these damaging processes that end up leading to the brain injury," Professor Bruno Meloni from the Perron Institute said.It was found to have neuro-protective properties.The drug will be rolled out for trial to treat ischemic stroke on more than 30 healthy patients.
"Our goal is to try and administer something in the first hour, in the first golden hour after stroke," Meloni said.Liz Dallimore from Argenica Therapeutics said the study will ideally be done "by the end of this calendar year".The research has been 25 years in the making. It is hoped this drug can help people with other neurological conditions such as Alzheimer's and those suffering concussion.